91 related articles for article (PubMed ID: 9047040)
1. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
[TBL] [Abstract][Full Text] [Related]
2. Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.
Timour Q; Bui-Xuan B; Faucon G; Aupetit JF
Cardiovasc Drugs Ther; 1996 Sep; 10(4):447-54. PubMed ID: 8924058
[TBL] [Abstract][Full Text] [Related]
3. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
4. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
[TBL] [Abstract][Full Text] [Related]
6. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
[TBL] [Abstract][Full Text] [Related]
7. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
8. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
[TBL] [Abstract][Full Text] [Related]
9. Vulnerability to ventricular fibrillation related to ischaemia: comparison of the acute effects of beta-blockers and calcium antagonists.
Aupetit JF; Timour Q; Freysz M; Loufoua-Moundanga J; Omar S; Chevrel G; Faucon G
Arch Int Pharmacodyn Ther; 1994; 327(1):25-39. PubMed ID: 7944825
[TBL] [Abstract][Full Text] [Related]
10. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q
Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448
[TBL] [Abstract][Full Text] [Related]
13. Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias.
Barrett TD; Walker MJ
J Mol Cell Cardiol; 1998 May; 30(5):999-1008. PubMed ID: 9618240
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
[TBL] [Abstract][Full Text] [Related]
15. Novel transient outward and ultra-rapid delayed rectifier current antagonist, AVE0118, protects against ventricular fibrillation induced by myocardial ischemia.
Billman GE; Kukielka M
J Cardiovasc Pharmacol; 2008 Apr; 51(4):352-8. PubMed ID: 18427277
[TBL] [Abstract][Full Text] [Related]
16. Effects of transient myocardial ischemia on the ventricular defibrillation threshold.
Anastasiou-Nana MI; Tsagalou EP; Charitos C; Siafakas KX; Drakos S; Terrovitis JV; Ntalianis A; Doufas A; Mavrikakis J; Nanas JN
Pacing Clin Electrophysiol; 2005 Feb; 28(2):97-101. PubMed ID: 15679638
[TBL] [Abstract][Full Text] [Related]
17. Effects of diltiazem upon experimental ventricular dysrhythmias.
Patterson E; Eller BT; Lucchesi BR
J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
[TBL] [Abstract][Full Text] [Related]
18. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
[TBL] [Abstract][Full Text] [Related]
19. Ventricular fibrillation during acute coronary occlusion is related to the dilation of the ischemic region.
Barrabés JA; Garcia-Dorado D; Padilla F; Agulló L; Trobo L; Carballo J; Soler-Soler J
Basic Res Cardiol; 2002 Nov; 97(6):445-51. PubMed ID: 12395206
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
Hearse DJ; Ferrari R; Sutherland FJ
J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
